Press Releases Emyria Limited

Equities

Market Closed - Australian S.E. Other stock markets 01:49:39 2024-04-29 am EDT			5-day change	1st Jan Change
0.051 ^AUD	+4.08%		-8.93%	-1.92%

Apr. 23	Emyria to Raise AU$2.3 Million via Placement	MT
Apr. 10	Emyria Launches Empax Center	MT

Emyria opens Empax Centre to target care gaps in resistant PTSD	Apr. 10	AQ
Emyria welcomes top healthcare leader as chairman	Nov. 22	AQ
Emyria hails strong growth in clinical billings	23-10-26	AQ
Emyria set to begin MDMA study after securing local supply	23-09-26	AQ
Emyria provides unique combination of drug development and therapy delivery	23-09-07	AQ
Emyria advances development and commercialisation of unique drug products	23-08-01	AQ
Emyria expands mental health care capabilities with Pax Centre acquisition	23-07-03	AQ
Emyria hails ethics approval for MDMA-assisted clinical trial	23-06-08	AQ
Emyria launches new high potency Ultra-Pure CBD capsule	23-04-24	AQ
Emyria agrees licensing and commercialisation deal for EMD-RX5	23-04-04	AQ
Emyria thrilled with new collaboration for MDMA-assisted PTSD therapy	23-03-08	AQ
Emyria ramps up MDMA programs following Ã¢€˜incredibleÃ¢€™ TGA decision	23-02-07	AQ
Emyria welcomes dosing of first patient in Phase 3 anxiety trial	23-01-31	AQ
Emyria delighted to be accepted into prestigious US pain initiative	22-11-29	AQ
Emyria delighted to be accepted into prestigious US pain initiative	22-11-29	EQ
Emyria : Appendix 4C - Quarterly	22-07-27	PU
Emyria : Appendix 4C - Quarterly	22-04-26	PU
Emyria : Broker Briefing Presentation	22-03-24	PU
Emyria : Addendum to Notice of Meeting and Proxy Form	22-03-18	PU
Emyria : Hidden Gems Webinar Presentation	22-03-03	PU

No results for this search